Dr. Reddy’s Laboratories
VC Fund
Hyderabad, India
Dr. Reddy’s Laboratories is an integrated pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active pharmaceutical ingredients (API) businessand custom pharmaceutical services (CPS) business, and Proprietary Products segment, which consists of DRL’s new chemical entities (NCEs) business, its Differentiated Formulations business and its dermatology focused specialty business operated through Promius Pharma.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Dr. Reddy’s Laboratories invests in
Stages Dr. Reddy’s Laboratories invests in
Countries Dr. Reddy’s Laboratories invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biopharma 2 (50%)
- Health Care 2 (50%)
- Life Science 2 (50%)
- Biotechnology 2 (50%)
- Medical 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Corporate Round 1 (25%)
- Post-IPO Equity 1 (25%)
Country
- India 2 (50%)
- United States 2 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Archana Bhaskar
Executive Vice President & Executive
|
Executive Vice President & Executive | Total investments: 0 | Find email | |
Christel Kronig
Senior Analytical Scientist
|
Senior Analytical Scientist | Total investments: 0 | Find email | |
Erez Israeli
Chief Executive Officer; Chief Operating Officer, Operations & Executive
|
Chief Executive Officer; Chief Operating Officer, Operations & Executive | Total investments: 0 | Find email | |
|
G.V. Prasad
Chief Executive Officer, Co-Chairman of the Board, Director & Managing Director
|
Chief Executive Officer, Co-Chairman of the Board, Director & Managing Director | Total investments: 0 | Find email | |
|
Marc Kikuchi
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
YouLabs
|
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting healthcare for South Asians from reactive medicine to proactive prevention. the company is building a native health-data graph to establish demographic-specific clinical reference standards.Through its ultra-premium, physician-managed conciergesubscription called the 150 Programme, YouLabs delivers hyper-personalized diagnostic tracking, metabolic profiling, and custom peptide/supplement maps to high-net-worth individuals and executives via a unique WhatsApp-based AI interface. | $2.6M / Seed / Jun 12, 2026 | |
Coya Therapeutics
|
Coya Therapeutics is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease. The company’s proprietary CTreg (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing forserial infusions. Through our patented TAI (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) platforms, Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson’s, Alzheimer’s, FTD and autoimmune diseases. | $11.1M / Post-IPO Equity / Jan 30, 2026 | |
Dr Reddy’s Laboratories Russia
|
Dr. Reddy's Russia webpage represents the operations of Dr. Reddy's Laboratories, an international pharmaceutical company, in the Russian Federation, focusing on distributing medicines and supporting healthcare needs. The site conveys the company's commitment to delivering affordable, accessible, and innovative pharmaceuticals,driven by the principle "Good Health Can't Wait". | $65.3M / Corporate Round / Jul 25, 2025 | |
|
Perlecan Pharma
|
An India-based integrated drug development company. | $52.5M / Series A / Sep 30, 2005 |
Co-Investors
Citi
1 deal together
Crane Venture Partners
1 deal together
Greenlight Capital
1 deal together
ICICI Venture
1 deal together
Matrix Pharmacorp
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Dr. Reddy’s Laboratories invest in?
Dr. Reddy’s Laboratories invests primarily in Biopharma, Health Care and Life Science startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dr. Reddy’s Laboratories?
Public channels for Dr. Reddy’s Laboratories include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Dr. Reddy’s Laboratories?
The team at Dr. Reddy’s Laboratories includes Archana Bhaskar (Executive Vice President & Executive), Christel Kronig (Senior Analytical Scientist) and Erez Israeli (Chief Executive Officer; Chief Operating Officer, Operations & Executive), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
